Multidisciplinary team for the diagnosis and treatment of 2 cases of primary intestinal yolk sac tumor

References

1. 1.↵
   2. Teilum G.

   Endodermal sinus tumors of the ovary and testis. Comparative morphogenesis of the so-called mesonephroma ovarii (Schill’r) and extraembryonic (yolk sac-allantoic) structures of the rat's placenta. Cancer. 1959; 12: 1092–105.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.
   2. Ulbright TM.

   Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol. 2005; 18(Suppl 2):S61–79.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.
   2. Young RH.

   The yolk sac tumor: reflections on a remarkable neoplasm and two of the many intrigued by it—Gunnar Teilum and Aleksander Talerman—and the bond it formed between them. Int J Surg Pathol. 2014; 22: 677–87.

   OpenUrlCrossRefPubMed
4. 4.↵
   2. Young RH,
   3. Teilum D,
   4. Talerman A.

   History of gynecological pathology XXV. Dr Gunnar Teilum. Int J Gynecol Pathol. 2013; 32: 520–7.

   OpenUrlCrossRefPubMed
5. 5.↵
   2. Sudour-Bonnange H,
   3. Orbach D,
   4. Kalfa N,
   5. Fasola S,
   6. Patte C.

   Germ cell tumors in atypical locations: experience of the TGM 95 SFCE trial. J Pediatr Hematol Oncol. 2014; 36: 646–8.

   OpenUrl
6. 6.↵
   2. Merchant A,
   3. Stewart RW.

   Sacrococcygeal yolk sac tumor presenting as subcutaneous fluid collection initially treated as abscess. Southern Med J. 2010; 103: 1068–70.

   OpenUrlPubMed
7. 7.
   2. Bremmer F,
   3. Ströbel P.

   Mediastinale Keimzelltumoren. Pathologe. 2016; 37: 441–8.

   OpenUrl
8. 8.
   2. Guo YL,
   3. Zhang YL,
   4. Zhu JQ.

   Primary yolk sac tumor of the retroperitoneum: a case report and review of the literature. Oncol Lett. 2014; 8: 556–60.

   OpenUrl
9. 9.↵
   2. Young RH,
   3. Scully RE.

   Endodermal sinus tumor of the vagina: a report of nine cases and review of the literature. Gynecol Oncol. 1984; 18: 380–92.

   OpenUrlCrossRefPubMed
10. 10.↵
    2. Filho BCA,
    3. McHugh JB,
    4. Carrau RL,
    5. Kassam AB.

    Yolk sac tumor in the nasal cavity. Am J Otolaryngol. 2008; 29: 250–4.

    OpenUrlPubMed
11. 11.↵
    2. Kiratli H,
    3. Erkan Balcı K,
    4. Güler G.

    Primary orbital endodermal sinus tumor (yolk sac tumor). J Am Assoc Pediatr Ophthalmol Strabismus. 2008; 12: 623–5.

    OpenUrl
12. 12.↵
    2. Pelosi G,
    3. Petrella F,
    4. Sandri MT,
    5. Spaggiari L,
    6. Galetta D,
    7. Viale G.

    A primary pure yolk sac tumor of the lung exhibiting CDX-2 immunoreactivity and increased serum levels of alkaline phosphatase intestinal isoenzyme. Int J Surg Pathol. 2006; 14: 247–51.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.
    2. Yalaza M,
    3. Kafadar MT,
    4. Turkan A.

    Gastric cancer with adenocarcinoma and yolk sac tumor components: a rare entity. North Clin Istanb. 2017; 4: 275–8.

    OpenUrl
14. 14.↵
    2. Mui WH,
    3. Lee KC,
    4. Chiu SC,
    5. Pang CY,
    6. Chu SK,
    7. Man CW, et al.

    Primary yolk sac tumour of the urinary bladder: a case report and review of the literature. Oncol Lett. 2014; 7: 199–202.

    OpenUrlPubMed
15. 15.
    2. Rossi R,
    3. Stacchiotti D,
    4. Bernardini MG,
    5. Calvieri G,
    6. Lo Voi R.

    Primary yolk sac tumor of the endometrium: a case report and review of the literature. Am J Obstet Gynecol. 2011; 204: e3–4.

    OpenUrlPubMed
16. 16.↵
    2. Alhamss S,
    3. Al-Halbouni L,
    4. Al-Qasem K,
    5. Al-Daghmin A.

    Case report: extragonadal mixed germ cell tumor in the thigh. Urol Case Rep. 2018; 16: 104–6.

    OpenUrl
17. 17.↵
    2. Nogales FF,
    3. Dulcey I.

    The secondary human yolk sac has an immunophenotype indicative of both hepatic and intestinal differentiation. Int J Dev Biol. 2012; 56: 755–60.

    OpenUrl
18. 18.↵
    2. Dabir PD,
    3. Svanholm H,
    4. Christiansen JJ.

    SATB2 is a supplementary immunohistochemical marker to CDX2 in the diagnosis of colorectal carcinoma metastasis in an unknown primary. APMIS. 2018; 126: 494–500.

    OpenUrl
19. 19.↵
    2. Zhou SM,
    3. Venkatramani R,
    4. Gomulia E,
    5. Shillingford N,
    6. Wang L.

    The diagnostic and prognostic value of SALL4 in hepatoblastoma. Histopathology. 2016; 69: 822–30.

    OpenUrl
20. 20.↵
    2. Cao DF,
    3. Guo SP,
    4. Allan RW,
    5. Molberg KH,
    6. Peng Y.

    SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol. 2009; 33: 894–904.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.
    2. Cao DF,
    3. Li JP,
    4. Guo CC,
    5. Allan RW,
    6. Humphrey PA.

    SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol. 2009; 33: 1065–77.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    2. Wang FH,
    3. Liu AJ,
    4. Peng Y,
    5. Rakheja D,
    6. Wei LX,
    7. Xue DB, et al.

    Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. Am J Surg Pathol. 2009; 33: 1529–39.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    2. Fukunaga M,
    3. Miyazawa Y,
    4. Harada T,
    5. Ushigome S,
    6. Ishikawa E.

    Yolk sac tumour of the ear. Histopathology. 1995; 27: 563–7.

    OpenUrlPubMed
24. 24.↵
    2. Harano K,
    3. Ando M,
    4. Sasajima Y,
    5. Yunokawa M,
    6. Yonemori K,
    7. Shimizu C, et al.

    Primary yolk sac tumor of the omentum: a case report and literature review. Case Rep Oncol. 2012; 5: 671–5.

    OpenUrl
25. 25.↵
    2. Oosterhuis JW,
    3. Stoop H,
    4. Honecker F,
    5. Looijenga LHJ.

    Why human extragonadal germ cell tumours occur in the midline of the body: old concepts, new perspectives. Int J Androl. 2007; 30: 256–64.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    2. Ravishankar S,
    3. Malpica A,
    4. Ramalingam P,
    5. Euscher ED.

    Yolk sac tumor in extragonadal pelvic sites: still a diagnostic challenge. Am J Surg Pathol. 2017; 41: 1–11.

    OpenUrl
27. 27.↵
    2. Gershenson DM.

    Management of ovarian germ cell tumors. J Clin Oncol. 2007; 25: 2938–43.

    OpenUrlAbstract/FREE Full Text
28. 28.↵
    2. Guida M,
    3. Pignata S,
    4. Palumbo AR,
    5. Miele G,
    6. Marra ML,
    7. Visconti F, et al.

    Laparoscopic treatment of a Yolk Sac Tumor: case report and literature review. Transl Med UniSa. 2013; 7: 1–5.

    OpenUrl
29. 29.↵
    2. Nawa A,
    3. Obata N,
    4. Kikkawa F,
    5. Kawai M,
    6. Nagasaka T,
    7. Goto S, et al.

    Prognostic factors of patients with yolk sac tumors of the ovary. Am J Obstet Gynecol. 2001; 184: 1182–8.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.↵
    2. Brown J,
    3. Friedlander M,
    4. Backes FJ,
    5. Harter P,
    6. O'Connor DM,
    7. de la Motte Rouge T, et al.

    Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors. Int J Gynecol Cancer. 2014; 24: S48–54.

    OpenUrlAbstract/FREE Full Text
31. 31.
    2. Li J,
    3. Yang WT,
    4. Wu XH.

    Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients. Gynecol Oncol. 2007; 105: 769-75.

    OpenUrlCrossRefPubMed
32. 32.↵
    2. Talukdar S,
    3. Kumar S,
    4. Bhatla N,
    5. Mathur S,
    6. Thulkar S,
    7. Kumar L.

    Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary. Gynecol Oncol. 2014; 132: 28–32.

    OpenUrlCrossRefPubMed
33. 33.↵
    2. Laforest A,
    3. Aparicio T,
    4. Zaanan A,
    5. Silva FP,
    6. Didelot A,
    7. Desbeaux A, et al.

    ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma. Eur J Cancer. 2014; 50: 1740–6.

    OpenUrlCrossRefPubMed